In light of the recently published OPRA trial, could one consider organ preservation as a standard treatment option for appropriately selected patients treated with total neoadjuvant therapy for locally advanced rectal cancer?   


Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Fort Belvoir Community Hospital
Certainly, longer follow up and more direct random...
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Washington University School of Medicine
One thing that the OPRA study does seem to show is...
Sign in or Register to read more